Secondary corpus callosum abnormalities associated with antiepileptic drugs in temporal lobe epilepsy: A diffusion tensor imaging study

Neuroradiology Journal

Volumn 24, Issue 2, 2011, Pages 316-323

  Günbey, Hediye Pinar ^a   Ercan, K ^b   Findikoglu A S ^c   Bilir, E ^d   Karaoglanoglu, M ^b   Komurcu, F ^b   Alhan, A ^e  

^a Department of Pediatrics   (Turkey)

^b ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c Erzincan Hospital   (Turkey)

^d GAZI UNIVERSITY   (Turkey)

^e UFUK UNIVERSITY   (Turkey)

Author keywords

Antiepileptic drug; Corpus callosum; Diffusion tensor imaging; Temporal lobe epilepsy

Indexed keywords

ANTICONVULSIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; DIFFUSION TENSOR IMAGING; DISEASE DURATION; FEMALE; FRACTIONAL ANISOTROPY; GENDER; HUMAN; MALE; TEMPORAL LOBE EPILEPSY; TREATMENT DURATION; WHITE MATTER;

EID: 79958787850     PISSN: 19714009     EISSN: None     Source Type: Journal    
DOI: 10.1177/197140091102400223     Document Type: Article

References (26)

1. Focke NK, Yogarajah M, Bonelli SB, et al. Voxel-based diffusion tensor imaging in patients with mesial temporal lobe epilepsy and hippocampal sclerosis. Neuroimage. 2008; 40: 728-737.
2. Arfanakis K, Hermann BP, Rogers BP, et al. Diffusion tensor MRI in temporal lobe epilepsy. Magn Reson Imaging. 2002; 20: 511-519. (Pubitemid 35304036)
3. Bernasconi N, Duchesne S, Janke A. Whole-brain voxel-based statistical analysis of gray matter and white matter in temporal lobe epilepsy. Neuroimage. 2004; 23: 717-723. (Pubitemid 39370622)
4. Weber B, Luders E, Faber J, et al. Distinct regional atrophy in the corpus callosum of patients with temporal lobe epilepsy. Brain. 2007; 130: 3149-3154. (Pubitemid 350209063)
5. Thivard L, Lehericy S, Krainik A. Diffusion tensor imaging in medial temporal epilepsy with hippocampal sclerosis. Neuroimage. 2005; 28: 682-690. (Pubitemid 41540376)
6. Spencer SS. Neural networks in human epilepsy: evidence of and implications for treatment. Epilepsia. 2002; 43: 219-227. (Pubitemid 34260378)
7. Gloor P, Salanova V, Olivier A. The human dorsal hippocampal commissure. Brain. 1993; 116: 1249-1273.
8. Spencer SS, Spencer DD, Williamson PD, et al. Corpus callosotomy for epilpesy, I: seizure effects. Neurology. 1988; 38: 19-24.
9. Witelson S.F. Hand and sex differences in the isthmus and genu of the human corpus callosum; a postmortem morphological study. Brain. 1989; 112: 799-835. (Pubitemid 19151171)
10. Huang H, Zhang J, Jiang H, et al. DTI tractography based parcellation of white matter: application of the mid-sagittal morphology of corpus callosum. NeuroImage. 2005; 26: 295-305.
11. Hermann B, Hansen R, Sidenberg M, et al. Neurodevelopmental vulnerability of the corpus callosum to childhood onset localization-related epilepsy. NeuroImage. 2003; 18: 284-292. (Pubitemid 36269140)
12. Kim H, Piao Z, Liu P, et al. Secondary white matter degeneration of the corpus callosum in patients with intractable temporal lobe epilepsy: A diffusion tensor imaging study. Epilepsy Research. 2008; 81: 136-142.
13. Le Bihan D, Mangin JF, Poupon C, et al. Diffusion tensor imaging: concepts and applications. J Magn Reson Imag. 2001; 13: 534-546. (Pubitemid 32231507)
14. Righini A, Pierpaoli C, Alger JR, et al. Brain parenchyma apparent diffusion coefficient alterations associated with experimental partial status epilepticus. Magn Res Imag. 1994; 12: 865-871. (Pubitemid 24253810)
15. Wieshmann UC, Symm M.R, Shorvon S. D. Diffusion changes in status epilepticus. Lancet. 1997; 350: 493-494.
16. Pulsipher DT, Seidenberg M, Morton JJ, et al. MRI volume loss of subcortical structures in unilateral temporal lobe epilepsy. Epilepsy Behav. 2007; 11: 442-449. (Pubitemid 350048495)
17. Pearl LP, Vezina GL, Saneto PR, et al. Cerebral MRI abnormalities associated with vigabatrin therapy. Epilepsia. 2009; 50(2): 184-194.
18. Kim SS, Chang KH, Kim ST, et al. Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity? Am J Neuroradiol. 1999; 20: 125-129. (Pubitemid 30417681)
19. Polster T, Hoppe M, Ebner A. Transient lesion in the splenium of the corpus callosum: three further cases in epileptic patients and a pathophysiological hypothesis. J Neurol Neurosurg Psychiatry. 2001; 70(4): 459-463. (Pubitemid 32269681)
20. Gurtler S, Ebner A, Tuxhorn I, et al. Transient lesion in the splenium of the corpus callosum and antiepileptic drug withdrawal. Neurology. 2005; 65(7): 1032-1036.
21. Prilipko O, Delavelle J, Lazeyras F, et al. Reversible cytotoxic edema in the splenium of the corpus callosum related to antiepileptic treatment: Report of two cases and literature review. Epilepsia. 2005; 46(10): 1633-1636.
22. Gross D.W, Concha L, Beaulieu C. Extratemporal white matter abnormalities in mesial temporal lobe epilepsy demonstrated with diffusion tensor imaging. Epilepsia. 2006; 47: 1360-1363. (Pubitemid 44200417)
23. Beaulieu C. The basis of anisotropic water diffusion in the nervous system-a technical review. NMR Biomed. 2002; 15: 435-455. (Pubitemid 36054508)
24. Pierpaoli C, Barnett A, Pajevic S. Water diffusion changes in Wallerian degeneration and their dependence on white matter architecture. NeuroImage. 2001; 13: 1174-1185. (Pubitemid 32553548)
25. Kantarci K, Jack CR, Xu YC, et al. Mild cognitive impairment and Alzheimer disease: regional diffusivity of water. Radiology. 2001; 219: 101-107. (Pubitemid 32234060)
26. Concha L, Gross DW, Wheatley M, et al. Diffusion tensor imaging of time-dependent axonal and myelin degradation after corpus callosotomy in epilepsy patients. NeuroImage. 2006; 32: 1090-1099. (Pubitemid 44278665)